bullish
SD Biosensor IPO: Improving Investor Sentiment & Valuation Rerating
224 Views29 Jun 2021 12:31
Investor sentiment toward SD Biosensor's IPO appears to be changing, probably thanks to the surge in the share price of Seegene, the only valuation peer, in the aftermath of the COVID-19 mutant virus.
SUMMARY
(Sign Up to Access)Get started on the Smartkarma Research Network with a complimentary Preview Pass to:
- Unlock all research summaries
- Follow top, independent analysts
- Receive personalised alerts and emails
- Access Briefings, Analytics, and Events
Upgrade anytime to our paid plans for full-length research, real-time analyst discussions, and more.
Join a thriving community of 45,000+ investors, including the top global asset managers managing over $13trn in assets.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 4-minute read)
Discussions
(Paid Plans Only)
Price Chart(Sign Up to Access)
- SD Biosensor: Full Allocation Results, Index Floats, & Fast Entry Possibilities15 Jul 2021
- SD Biosensor Bookbuilding Results: The First Case of Disclosing Lockup Info in Detail08 Jul 2021
- SD Biosensor Bookbuilding Results07 Jul 2021
- SD Biosensor IPO: Improving Investor Sentiment & Valuation Rerating29 Jun 2021
- SD Biosensor Reduces IPO Price Range14 Jun 2021
- SD Biosensor Offering Price/Size Adjustment & Valuation Re-Review13 Jun 2021
- SD Biosensor IPO: Offering Detail, Valuation Issue, & Index Fast Entry Possibilities19 May 2021
x